# Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell Anemia

> **NCT00004492** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of North Carolina** · enrollment: 20 (estimated)

## Conditions studied

- Sickle Cell Anemia

## Interventions

- **DRUG:** clotrimazole
- **DRUG:** hydroxyurea

## Key facts

- **NCT ID:** NCT00004492
- **Lead sponsor:** University of North Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-10
- **Primary completion:** —
- **Final completion:** 2001-09
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2015-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004492, "Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell Anemia". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00004492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*